Oncology Therapeutic Drug Market
1 Oncology Therapeutic Drug Market Overview
1.1 Product Overview and Scope of Oncology Therapeutic Drug
1.2 Oncology Therapeutic Drug Segment by Type
1.2.1 Global Oncology Therapeutic Drug Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 Chemotherapy
1.2.3 Targeted Therapy
1.2.4 Immunotherapy
1.2.5 Hormonal Therapy
1.2.6 Others
1.3 Oncology Therapeutic Drug Segment by Application
1.3.1 Global Oncology Therapeutic Drug Sales Comparison by Application: (2022-2028)
1.3.2 Breast Cancer
1.3.3 Gastrointestinal Cancer
1.3.4 Prostate Cancer
1.3.5 Respiratory and Lung Cancer
1.3.6 Others
1.4 Global Oncology Therapeutic Drug Market Size Estimates and Forecasts
1.4.1 Global Oncology Therapeutic Drug Revenue 2017-2028
1.4.2 Global Oncology Therapeutic Drug Sales 2017-2028
1.4.3 Oncology Therapeutic Drug Market Size by Region: 2017 Versus 2021 Versus 2028
2 Oncology Therapeutic Drug Market Competition by Manufacturers
2.1 Global Oncology Therapeutic Drug Sales Market Share by Manufacturers (2017-2022)
2.2 Global Oncology Therapeutic Drug Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Oncology Therapeutic Drug Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Oncology Therapeutic Drug Manufacturing Sites, Area Served, Product Type
2.5 Oncology Therapeutic Drug Market Competitive Situation and Trends
2.5.1 Oncology Therapeutic Drug Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Oncology Therapeutic Drug Players Market Share by Revenue
2.5.3 Global Oncology Therapeutic Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Oncology Therapeutic Drug Retrospective Market Scenario by Region
3.1 Global Oncology Therapeutic Drug Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Oncology Therapeutic Drug Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Oncology Therapeutic Drug Market Facts & Figures by Country
3.3.1 North America Oncology Therapeutic Drug Sales by Country
3.3.2 North America Oncology Therapeutic Drug Revenue by Country
3.3.3 United States
3.3.4 Canada
3.4 Europe Oncology Therapeutic Drug Market Facts & Figures by Country
3.4.1 Europe Oncology Therapeutic Drug Sales by Country
3.4.2 Europe Oncology Therapeutic Drug Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Oncology Therapeutic Drug Market Facts & Figures by Region
3.5.1 Asia Pacific Oncology Therapeutic Drug Sales by Region
3.5.2 Asia Pacific Oncology Therapeutic Drug Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 China Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America Oncology Therapeutic Drug Market Facts & Figures by Country
3.6.1 Latin America Oncology Therapeutic Drug Sales by Country
3.6.2 Latin America Oncology Therapeutic Drug Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.6.6 Colombia
3.7 Middle East and Africa Oncology Therapeutic Drug Market Facts & Figures by Country
3.7.1 Middle East and Africa Oncology Therapeutic Drug Sales by Country
3.7.2 Middle East and Africa Oncology Therapeutic Drug Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Oncology Therapeutic Drug Historic Market Analysis by Type
4.1 Global Oncology Therapeutic Drug Sales Market Share by Type (2017-2022)
4.2 Global Oncology Therapeutic Drug Revenue Market Share by Type (2017-2022)
4.3 Global Oncology Therapeutic Drug Price by Type (2017-2022)
5 Global Oncology Therapeutic Drug Historic Market Analysis by Application
5.1 Global Oncology Therapeutic Drug Sales Market Share by Application (2017-2022)
5.2 Global Oncology Therapeutic Drug Revenue Market Share by Application (2017-2022)
5.3 Global Oncology Therapeutic Drug Price by Application (2017-2022)
6 Key Companies Profiled
6.1 AbbVie
6.1.1 AbbVie Corporation Information
6.1.2 AbbVie Description and Business Overview
6.1.3 AbbVie Oncology Therapeutic Drug Sales, Revenue and Gross Margin (2017-2022)
6.1.4 AbbVie Oncology Therapeutic Drug Product Portfolio
6.1.5 AbbVie Recent Developments/Updates
6.2 Amgen
6.2.1 Amgen Corporation Information
6.2.2 Amgen Description and Business Overview
6.2.3 Amgen Oncology Therapeutic Drug Sales, Revenue and Gross Margin (2017-2022)
6.2.4 Amgen Oncology Therapeutic Drug Product Portfolio
6.2.5 Amgen Recent Developments/Updates
6.3 Astellas Pharma
6.3.1 Astellas Pharma Corporation Information
6.3.2 Astellas Pharma Description and Business Overview
6.3.3 Astellas Pharma Oncology Therapeutic Drug Sales, Revenue and Gross Margin (2017-2022)
6.3.4 Astellas Pharma Oncology Therapeutic Drug Product Portfolio
6.3.5 Astellas Pharma Recent Developments/Updates
6.4 AstraZeneca
6.4.1 AstraZeneca Corporation Information
6.4.2 AstraZeneca Description and Business Overview
6.4.3 AstraZeneca Oncology Therapeutic Drug Sales, Revenue and Gross Margin (2017-2022)
6.4.4 AstraZeneca Oncology Therapeutic Drug Product Portfolio
6.4.5 AstraZeneca Recent Developments/Updates
6.5 Bayer
6.5.1 Bayer Corporation Information
6.5.2 Bayer Description and Business Overview
6.5.3 Bayer Oncology Therapeutic Drug Sales, Revenue and Gross Margin (2017-2022)
6.5.4 Bayer Oncology Therapeutic Drug Product Portfolio
6.5.5 Bayer Recent Developments/Updates
6.6 Biogen
6.6.1 Biogen Corporation Information
6.6.2 Biogen Description and Business Overview
6.6.3 Biogen Oncology Therapeutic Drug Sales, Revenue and Gross Margin (2017-2022)
6.6.4 Biogen Oncology Therapeutic Drug Product Portfolio
6.6.5 Biogen Recent Developments/Updates
6.7 Bristol Myers Squibb
6.6.1 Bristol Myers Squibb Corporation Information
6.6.2 Bristol Myers Squibb Description and Business Overview
6.6.3 Bristol Myers Squibb Oncology Therapeutic Drug Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Bristol Myers Squibb Oncology Therapeutic Drug Product Portfolio
6.7.5 Bristol Myers Squibb Recent Developments/Updates
6.8 Celgene
6.8.1 Celgene Corporation Information
6.8.2 Celgene Description and Business Overview
6.8.3 Celgene Oncology Therapeutic Drug Sales, Revenue and Gross Margin (2017-2022)
6.8.4 Celgene Oncology Therapeutic Drug Product Portfolio
6.8.5 Celgene Recent Developments/Updates
6.9 Eisai
6.9.1 Eisai Corporation Information
6.9.2 Eisai Description and Business Overview
6.9.3 Eisai Oncology Therapeutic Drug Sales, Revenue and Gross Margin (2017-2022)
6.9.4 Eisai Oncology Therapeutic Drug Product Portfolio
6.9.5 Eisai Recent Developments/Updates
6.10 Eli Lilly and Company
6.10.1 Eli Lilly and Company Corporation Information
6.10.2 Eli Lilly and Company Description and Business Overview
6.10.3 Eli Lilly and Company Oncology Therapeutic Drug Sales, Revenue and Gross Margin (2017-2022)
6.10.4 Eli Lilly and Company Oncology Therapeutic Drug Product Portfolio
6.10.5 Eli Lilly and Company Recent Developments/Updates
6.11 Gilead Sciences
6.11.1 Gilead Sciences Corporation Information
6.11.2 Gilead Sciences Oncology Therapeutic Drug Description and Business Overview
6.11.3 Gilead Sciences Oncology Therapeutic Drug Sales, Revenue and Gross Margin (2017-2022)
6.11.4 Gilead Sciences Oncology Therapeutic Drug Product Portfolio
6.11.5 Gilead Sciences Recent Developments/Updates
6.12 Ipsen
6.12.1 Ipsen Corporation Information
6.12.2 Ipsen Oncology Therapeutic Drug Description and Business Overview
6.12.3 Ipsen Oncology Therapeutic Drug Sales, Revenue and Gross Margin (2017-2022)
6.12.4 Ipsen Oncology Therapeutic Drug Product Portfolio
6.12.5 Ipsen Recent Developments/Updates
6.13 Johnson and Johnson
6.13.1 Johnson and Johnson Corporation Information
6.13.2 Johnson and Johnson Oncology Therapeutic Drug Description and Business Overview
6.13.3 Johnson and Johnson Oncology Therapeutic Drug Sales, Revenue and Gross Margin (2017-2022)
6.13.4 Johnson and Johnson Oncology Therapeutic Drug Product Portfolio
6.13.5 Johnson and Johnson Recent Developments/Updates
6.14 Merck
6.14.1 Merck Corporation Information
6.14.2 Merck Oncology Therapeutic Drug Description and Business Overview
6.14.3 Merck Oncology Therapeutic Drug Sales, Revenue and Gross Margin (2017-2022)
6.14.4 Merck Oncology Therapeutic Drug Product Portfolio
6.14.5 Merck Recent Developments/Updates
6.15 Novartis
6.15.1 Novartis Corporation Information
6.15.2 Novartis Oncology Therapeutic Drug Description and Business Overview
6.15.3 Novartis Oncology Therapeutic Drug Sales, Revenue and Gross Margin (2017-2022)
6.15.4 Novartis Oncology Therapeutic Drug Product Portfolio
6.15.5 Novartis Recent Developments/Updates
6.16 Otsuka Pharmaceutical
6.16.1 Otsuka Pharmaceutical Corporation Information
6.16.2 Otsuka Pharmaceutical Oncology Therapeutic Drug Description and Business Overview
6.16.3 Otsuka Pharmaceutical Oncology Therapeutic Drug Sales, Revenue and Gross Margin (2017-2022)
6.16.4 Otsuka Pharmaceutical Oncology Therapeutic Drug Product Portfolio
6.16.5 Otsuka Pharmaceutical Recent Developments/Updates
6.17 Pfizer
6.17.1 Pfizer Corporation Information
6.17.2 Pfizer Oncology Therapeutic Drug Description and Business Overview
6.17.3 Pfizer Oncology Therapeutic Drug Sales, Revenue and Gross Margin (2017-2022)
6.17.4 Pfizer Oncology Therapeutic Drug Product Portfolio
6.17.5 Pfizer Recent Developments/Updates
6.18 F. Hoffmann-La Roche
6.18.1 F. Hoffmann-La Roche Corporation Information
6.18.2 F. Hoffmann-La Roche Oncology Therapeutic Drug Description and Business Overview
6.18.3 F. Hoffmann-La Roche Oncology Therapeutic Drug Sales, Revenue and Gross Margin (2017-2022)
6.18.4 F. Hoffmann-La Roche Oncology Therapeutic Drug Product Portfolio
6.18.5 F. Hoffmann-La Roche Recent Developments/Updates
6.19 Sanofi
6.19.1 Sanofi Corporation Information
6.19.2 Sanofi Oncology Therapeutic Drug Description and Business Overview
6.19.3 Sanofi Oncology Therapeutic Drug Sales, Revenue and Gross Margin (2017-2022)
6.19.4 Sanofi Oncology Therapeutic Drug Product Portfolio
6.19.5 Sanofi Recent Developments/Updates
6.20 Takeda Pharmaceutical
6.20.1 Takeda Pharmaceutical Corporation Information
6.20.2 Takeda Pharmaceutical Oncology Therapeutic Drug Description and Business Overview
6.20.3 Takeda Pharmaceutical Oncology Therapeutic Drug Sales, Revenue and Gross Margin (2017-2022)
6.20.4 Takeda Pharmaceutical Oncology Therapeutic Drug Product Portfolio
6.20.5 Takeda Pharmaceutical Recent Developments/Updates
6.21 Teva Pharmaceutical Industries
6.21.1 Teva Pharmaceutical Industries Corporation Information
6.21.2 Teva Pharmaceutical Industries Oncology Therapeutic Drug Description and Business Overview
6.21.3 Teva Pharmaceutical Industries Oncology Therapeutic Drug Sales, Revenue and Gross Margin (2017-2022)
6.21.4 Teva Pharmaceutical Industries Oncology Therapeutic Drug Product Portfolio
6.21.5 Teva Pharmaceutical Industries Recent Developments/Updates
7 Oncology Therapeutic Drug Manufacturing Cost Analysis
7.1 Oncology Therapeutic Drug Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Oncology Therapeutic Drug
7.4 Oncology Therapeutic Drug Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Oncology Therapeutic Drug Distributors List
8.3 Oncology Therapeutic Drug Customers
9 Oncology Therapeutic Drug Market Dynamics
9.1 Oncology Therapeutic Drug Industry Trends
9.2 Oncology Therapeutic Drug Market Drivers
9.3 Oncology Therapeutic Drug Market Challenges
9.4 Oncology Therapeutic Drug Market Restraints
10 Global Market Forecast
10.1 Oncology Therapeutic Drug Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Oncology Therapeutic Drug by Type (2023-2028)
10.1.2 Global Forecasted Revenue of Oncology Therapeutic Drug by Type (2023-2028)
10.2 Oncology Therapeutic Drug Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Oncology Therapeutic Drug by Application (2023-2028)
10.2.2 Global Forecasted Revenue of Oncology Therapeutic Drug by Application (2023-2028)
10.3 Oncology Therapeutic Drug Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Oncology Therapeutic Drug by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Oncology Therapeutic Drug by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Oncology Therapeutic Drug Sales Growth Rate Comparison by Type (2022-2028) & (K Units) & (US$ Million)
Table 2. Global Oncology Therapeutic Drug Sales Growth Rate Comparison by Application (2022-2028) & (K Units) & (US$ Million)
Table 3. Global Oncology Therapeutic Drug Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
Table 4. Global Oncology Therapeutic Drug Market Competitive Situation by Manufacturers in 2021
Table 5. Global Oncology Therapeutic Drug Sales (K Units) of Key Manufacturers (2017-2022)
Table 6. Global Oncology Therapeutic Drug Sales Market Share by Manufacturers (2017-2022)
Table 7. Global Oncology Therapeutic Drug Revenue (US$ Million) by Manufacturers (2017-2022)
Table 8. Global Oncology Therapeutic Drug Revenue Share by Manufacturers (2017-2022)
Table 9. Global Market Oncology Therapeutic Drug Average Price (US$/Unit) of Key Manufacturers (2017-2022)
Table 10. Manufacturers Oncology Therapeutic Drug Manufacturing Sites and Area Served
Table 11. Manufacturers Oncology Therapeutic Drug Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Oncology Therapeutic Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oncology Therapeutic Drug as of 2021)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Oncology Therapeutic Drug Sales by Region (2017-2022) & (K Units)
Table 16. Global Oncology Therapeutic Drug Sales Market Share by Region (2017-2022)
Table 17. Global Oncology Therapeutic Drug Revenue by Region (2017-2022) & (US$ Million)
Table 18. Global Oncology Therapeutic Drug Revenue Market Share by Region (2017-2022)
Table 19. North America Oncology Therapeutic Drug Sales by Country (2017-2022) & (K Units)
Table 20. North America Oncology Therapeutic Drug Sales Market Share by Country (2017-2022)
Table 21. North America Oncology Therapeutic Drug Revenue by Country (2017-2022) & (US$ Million)
Table 22. North America Oncology Therapeutic Drug Revenue Market Share by Country (2017-2022)
Table 23. Europe Oncology Therapeutic Drug Sales by Country (2017-2022) & (K Units)
Table 24. Europe Oncology Therapeutic Drug Sales Market Share by Country (2017-2022)
Table 25. Europe Oncology Therapeutic Drug Revenue by Country (2017-2022) & (US$ Million)
Table 26. Europe Oncology Therapeutic Drug Revenue Market Share by Country (2017-2022)
Table 27. Asia Pacific Oncology Therapeutic Drug Sales by Region (2017-2022) & (K Units)
Table 28. Asia Pacific Oncology Therapeutic Drug Sales Market Share by Region (2017-2022)
Table 29. Asia Pacific Oncology Therapeutic Drug Revenue by Region (2017-2022) & (US$ Million)
Table 30. Asia Pacific Oncology Therapeutic Drug Revenue Market Share by Region (2017-2022)
Table 31. Latin America Oncology Therapeutic Drug Sales by Country (2017-2022) & (K Units)
Table 32. Latin America Oncology Therapeutic Drug Sales Market Share by Country (2017-2022)
Table 33. Latin America Oncology Therapeutic Drug Revenue by Country (2017-2022) & (US$ Million)
Table 34. Latin America Oncology Therapeutic Drug Revenue Market Share by Country (2017-2022)
Table 35. Middle East and Africa Oncology Therapeutic Drug Sales by Country (2017-2022) & (K Units)
Table 36. Middle East and Africa Oncology Therapeutic Drug Sales Market Share by Country (2017-2022)
Table 37. Middle East and Africa Oncology Therapeutic Drug Revenue by Country (2017-2022) & (US$ Million)
Table 38. Middle East and Africa Oncology Therapeutic Drug Revenue Market Share by Country (2017-2022)
Table 39. Global Oncology Therapeutic Drug Sales by Type (2017-2022) & (K Units)
Table 40. Global Oncology Therapeutic Drug Sales Market Share by Type (2017-2022)
Table 41. Global Oncology Therapeutic Drug Revenue by Type (2017-2022) & (US$ Million)
Table 42. Global Oncology Therapeutic Drug Revenue Share by Type (2017-2022)
Table 43. Global Oncology Therapeutic Drug Price by Type (2017-2022) & (US$/Unit)
Table 44. Global Oncology Therapeutic Drug Sales (K Units) by Application (2017-2022)
Table 45. Global Oncology Therapeutic Drug Sales Market Share by Application (2017-2022)
Table 46. Global Oncology Therapeutic Drug Revenue by Application (2017-2022) & (US$ Million)
Table 47. Global Oncology Therapeutic Drug Revenue Share by Application (2017-2022)
Table 48. Global Oncology Therapeutic Drug Price by Application (2017-2022) & (US$/Unit)
Table 49. AbbVie Corporation Information
Table 50. AbbVie Description and Business Overview
Table 51. AbbVie Oncology Therapeutic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 52. AbbVie Oncology Therapeutic Drug Product
Table 53. AbbVie Recent Developments/Updates
Table 54. Amgen Corporation Information
Table 55. Amgen Description and Business Overview
Table 56. Amgen Oncology Therapeutic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 57. Amgen Oncology Therapeutic Drug Product
Table 58. Amgen Recent Developments/Updates
Table 59. Astellas Pharma Corporation Information
Table 60. Astellas Pharma Description and Business Overview
Table 61. Astellas Pharma Oncology Therapeutic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 62. Astellas Pharma Oncology Therapeutic Drug Product
Table 63. Astellas Pharma Recent Developments/Updates
Table 64. AstraZeneca Corporation Information
Table 65. AstraZeneca Description and Business Overview
Table 66. AstraZeneca Oncology Therapeutic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 67. AstraZeneca Oncology Therapeutic Drug Product
Table 68. AstraZeneca Recent Developments/Updates
Table 69. Bayer Corporation Information
Table 70. Bayer Description and Business Overview
Table 71. Bayer Oncology Therapeutic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 72. Bayer Oncology Therapeutic Drug Product
Table 73. Bayer Recent Developments/Updates
Table 74. Biogen Corporation Information
Table 75. Biogen Description and Business Overview
Table 76. Biogen Oncology Therapeutic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 77. Biogen Oncology Therapeutic Drug Product
Table 78. Biogen Recent Developments/Updates
Table 79. Bristol Myers Squibb Corporation Information
Table 80. Bristol Myers Squibb Description and Business Overview
Table 81. Bristol Myers Squibb Oncology Therapeutic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 82. Bristol Myers Squibb Oncology Therapeutic Drug Product
Table 83. Bristol Myers Squibb Recent Developments/Updates
Table 84. Celgene Corporation Information
Table 85. Celgene Description and Business Overview
Table 86. Celgene Oncology Therapeutic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 87. Celgene Oncology Therapeutic Drug Product
Table 88. Celgene Recent Developments/Updates
Table 89. Eisai Corporation Information
Table 90. Eisai Description and Business Overview
Table 91. Eisai Oncology Therapeutic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 92. Eisai Oncology Therapeutic Drug Product
Table 93. Eisai Recent Developments/Updates
Table 94. Eli Lilly and Company Corporation Information
Table 95. Eli Lilly and Company Description and Business Overview
Table 96. Eli Lilly and Company Oncology Therapeutic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 97. Eli Lilly and Company Oncology Therapeutic Drug Product
Table 98. Eli Lilly and Company Recent Developments/Updates
Table 99. Gilead Sciences Corporation Information
Table 100. Gilead Sciences Description and Business Overview
Table 101. Gilead Sciences Oncology Therapeutic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 102. Gilead Sciences Oncology Therapeutic Drug Product
Table 103. Gilead Sciences Recent Developments/Updates
Table 104. Ipsen Corporation Information
Table 105. Ipsen Description and Business Overview
Table 106. Ipsen Oncology Therapeutic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 107. Ipsen Oncology Therapeutic Drug Product
Table 108. Ipsen Recent Developments/Updates
Table 109. Johnson and Johnson Corporation Information
Table 110. Johnson and Johnson Description and Business Overview
Table 111. Johnson and Johnson Oncology Therapeutic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 112. Johnson and Johnson Oncology Therapeutic Drug Product
Table 113. Johnson and Johnson Recent Developments/Updates
Table 114. Merck Corporation Information
Table 115. Merck Description and Business Overview
Table 116. Merck Oncology Therapeutic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 117. Merck Oncology Therapeutic Drug Product
Table 118. Merck Recent Developments/Updates
Table 119. Novartis Corporation Information
Table 120. Novartis Description and Business Overview
Table 121. Novartis Oncology Therapeutic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 122. Novartis Oncology Therapeutic Drug Product
Table 123. Novartis Recent Developments/Updates
Table 124. Otsuka Pharmaceutical Corporation Information
Table 125. Otsuka Pharmaceutical Description and Business Overview
Table 126. Otsuka Pharmaceutical Oncology Therapeutic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 127. Otsuka Pharmaceutical Oncology Therapeutic Drug Product
Table 128. Otsuka Pharmaceutical Recent Developments/Updates
Table 129. Pfizer Corporation Information
Table 130. Pfizer Description and Business Overview
Table 131. Pfizer Oncology Therapeutic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 132. Pfizer Oncology Therapeutic Drug Product
Table 133. Pfizer Recent Developments/Updates
Table 134. F. Hoffmann-La Roche Corporation Information
Table 135. F. Hoffmann-La Roche Description and Business Overview
Table 136. F. Hoffmann-La Roche Oncology Therapeutic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 137. F. Hoffmann-La Roche Oncology Therapeutic Drug Product
Table 138. F. Hoffmann-La Roche Recent Developments/Updates
Table 139. Sanofi Corporation Information
Table 140. Sanofi Description and Business Overview
Table 141. Sanofi Oncology Therapeutic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 142. Sanofi Oncology Therapeutic Drug Product
Table 143. Sanofi Recent Developments/Updates
Table 144. Takeda Pharmaceutical Corporation Information
Table 145. Takeda Pharmaceutical Description and Business Overview
Table 146. Takeda Pharmaceutical Oncology Therapeutic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 147. Takeda Pharmaceutical Oncology Therapeutic Drug Product
Table 148. Takeda Pharmaceutical Recent Developments/Updates
Table 149. Teva Pharmaceutical Industries Corporation Information
Table 150. Teva Pharmaceutical Industries Description and Business Overview
Table 151. Teva Pharmaceutical Industries Oncology Therapeutic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 152. Teva Pharmaceutical Industries Oncology Therapeutic Drug Product
Table 153. Teva Pharmaceutical Industries Recent Developments/Updates
Table 154. Production Base and Market Concentration Rate of Raw Material
Table 155. Key Suppliers of Raw Materials
Table 156. Oncology Therapeutic Drug Distributors List
Table 157. Oncology Therapeutic Drug Customers List
Table 158. Oncology Therapeutic Drug Market Trends
Table 159. Oncology Therapeutic Drug Market Drivers
Table 160. Oncology Therapeutic Drug Market Challenges
Table 161. Oncology Therapeutic Drug Market Restraints
Table 162. Global Oncology Therapeutic Drug Sales Forecast by Type (2023-2028) & (K Units)
Table 163. Global Oncology Therapeutic Drug Sales Market Share Forecast by Type (2023-2028)
Table 164. Global Oncology Therapeutic Drug Revenue Forecast by Type (2023-2028) & (US$ Million)
Table 165. Global Oncology Therapeutic Drug Revenue Market Share Forecast by Type (2023-2028)
Table 166. Global Oncology Therapeutic Drug Sales Forecast by Application (2023-2028) & (K Units)
Table 167. Global Oncology Therapeutic Drug Sales Market Share Forecast by Application (2023-2028)
Table 168. Global Oncology Therapeutic Drug Revenue Forecast by Application (2023-2028) & (US$ Million)
Table 169. Global Oncology Therapeutic Drug Revenue Market Share Forecast by Application (2023-2028)
Table 170. Global Oncology Therapeutic Drug Sales Forecast by Region (2023-2028) & (K Units)
Table 171. Global Oncology Therapeutic Drug Sales Market Share Forecast by Region (2023-2028)
Table 172. Global Oncology Therapeutic Drug Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 173. Global Oncology Therapeutic Drug Revenue Market Share Forecast by Region (2023-2028)
Table 174. Research Programs/Design for This Report
Table 175. Key Data Information from Secondary Sources
Table 176. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Oncology Therapeutic Drug
Figure 2. Global Oncology Therapeutic Drug Market Share by Type in 2021 & 2028
Figure 3. Chemotherapy Product Picture
Figure 4. Targeted Therapy Product Picture
Figure 5. Immunotherapy Product Picture
Figure 6. Hormonal Therapy Product Picture
Figure 7. Others Product Picture
Figure 8. Global Oncology Therapeutic Drug Market Share by Application in 2021 & 2028
Figure 9. Breast Cancer
Figure 10. Gastrointestinal Cancer
Figure 11. Prostate Cancer
Figure 12. Respiratory and Lung Cancer
Figure 13. Others
Figure 14. Global Oncology Therapeutic Drug Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 15. Global Oncology Therapeutic Drug Market Size (2017-2028) & (US$ Million)
Figure 16. Global Oncology Therapeutic Drug Sales (2017-2028) & (K Units)
Figure 17. Oncology Therapeutic Drug Sales Share by Manufacturers in 2021
Figure 18. Global Oncology Therapeutic Drug Revenue Share by Manufacturers in 2021
Figure 19. The Global 5 and 10 Largest Oncology Therapeutic Drug Players: Market Share by Revenue in 2021
Figure 20. Oncology Therapeutic Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 21. Global Oncology Therapeutic Drug Sales Market Share by Region (2017-2022)
Figure 22. Global Oncology Therapeutic Drug Sales Market Share by Region in 2021
Figure 23. Global Oncology Therapeutic Drug Revenue Market Share by Region (2017-2022)
Figure 24. Global Oncology Therapeutic Drug Revenue Market Share by Region in 2021
Figure 25. United States Oncology Therapeutic Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 26. Canada Oncology Therapeutic Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 27. Germany Oncology Therapeutic Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 28. France Oncology Therapeutic Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 29. U.K. Oncology Therapeutic Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 30. Italy Oncology Therapeutic Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 31. Russia Oncology Therapeutic Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 32. China Oncology Therapeutic Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 33. Japan Oncology Therapeutic Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 34. South Korea Oncology Therapeutic Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 35. India Oncology Therapeutic Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 36. Australia Oncology Therapeutic Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 37. China Taiwan Oncology Therapeutic Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 38. Indonesia Oncology Therapeutic Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 39. Thailand Oncology Therapeutic Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 40. Malaysia Oncology Therapeutic Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 41. Mexico Oncology Therapeutic Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 42. Brazil Oncology Therapeutic Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 43. Argentina Oncology Therapeutic Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 44. Colombia Oncology Therapeutic Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 45. Turkey Oncology Therapeutic Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 46. Saudi Arabia Oncology Therapeutic Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 47. UAE Oncology Therapeutic Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 48. Sales Market Share of Oncology Therapeutic Drug by Type (2017-2022)
Figure 49. Manufacturing Cost Structure of Oncology Therapeutic Drug
Figure 50. Manufacturing Process Analysis of Oncology Therapeutic Drug
Figure 51. Oncology Therapeutic Drug Industrial Chain Analysis
Figure 52. Channels of Distribution
Figure 53. Distributors Profiles
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed
Industry Market Size
